TriReme Medical, LLC v. AngioScore, Inc., No. 15-1504 (Fed. Cir. Feb. 5, 2016)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

AngioScore, Inc. (“AngioScore”) claims exclusive ownership of U.S. Patent Nos. 8,080,026 (“the ’026 p a- tent”), 8,454,636 (“the ’636 patent”) , and 8,721,667 (“the ’667 patent”) (collectively, “the AngioScore patents”). TriReme Medical, LLC ( “TriReme”), claiming to have received an assignment of an interest in the AngioScore patents from Dr. Chaim Lotan, brought suit for correction of inventorship. It sought to have Dr. Lotan named as an inventor on the patents pursuant to 35 U.S.C. § 256.